Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    PRC 04 - Press Conference 4

    • Type: Press Conference
    • Track: Other
    • Presentations: 7
    • Moderators:P.A. Bunn, Jr
    • Coordinates: 9/09/2015, 09:45 - 10:45, 108+110+112
    • +

      Abstract – Randomized Phase III Trial of Adjuvant Chemotherapy with or without Bevacizumab in Resected Non-Small Cell Lung Cancer (NSCLC): Results of E1505 - Dr. Heather Wakelee, Associate Professor of Medicine (Oncology) at the Stanford University Medical Center, Stanford, California

      09:53 - 10:01  |  Author(s): H.A. Wakelee

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PLEN 04 - Presidential Symposium Including Top 4 Abstracts

    • Type: Plenary
    • Track: Plenary
    • Presentations: 12
    • Moderators:T. Mok
    • Coordinates: 9/09/2015, 10:45 - 12:15, Plenary Hall (Bellco Theatre)
    • +

      PLEN04.03 - Randomized Phase III Trial of Adjuvant Chemotherapy with or without Bevacizumab in Resected Non-Small Cell Lung Cancer (NSCLC): Results of E1505

      11:07 - 11:19  |  Author(s): H.A. Wakelee

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 30 - New Kinase Targets

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:K. Park
    • Coordinates: 9/09/2015, 18:30 - 20:00, Four Seasons Ballroom F3+F4
    • +

      MINI30.04 - A Randomized Phase 2 Trial of Cabozantinib, Erlotinib or the Combination as 2nd or 3rd Line Therapy in EGFR Wild-Type NSCLC: ECOG-ACRIN E1512

      18:45 - 18:50  |  Author(s): J.W. Neal

      • Abstract

      Loading...

  • +

    MINI 31 - ALK

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:S. Malik
    • Coordinates: 9/09/2015, 18:30 - 20:00, Mile High Ballroom 1a-1f
    • +

      MINI31.13 - Symptoms and QOL with Ceritinib in ALK+ NSCLC Patients with/without Brain Metastases

      19:40 - 19:45  |  Author(s): L. Crinò

      • Abstract

      Loading...